Skip to Content
Jump to the top of the page

William Blair has been made aware of fraudulent activity involving individuals impersonating our employees and brand, including through fake websites, Instagram accounts, and messaging apps like WhatsApp and Telegram. If you have any questions or concerns about someone from William Blair contacting you, please reach out to us via our Contact Us form. Please note — William Blair will never initiate contact with you via messaging apps.

William Blair Thinking

  • The Quarterly Rx: Q3 2025 U.S. Biopharma Recap

    Biopharma bounced back in the third quarter, powered by the year’s first rate cut, a steady run of big M&A, and a wave of positive clinical data, especially from the latest IPO class.

    Read more
  • The Great Wealth Transfer: Five Actionable Steps

    With the Great Wealth Transfer on the horizon, there’s no greater moment than the present to take action on your financial future.

    Read more
  • 10 Questions to Ask Yourself Before Selling Your Business

    The most critical decisions about selling your business are the ones made well before any potential buyers have been contacted.

    Read more

Our Mission, Vision, and Values

At William Blair, we're committed to our colleagues, our clients, and our communities. Serving our clients starts with the capabilities and collaboration of our team—making our employees our most important asset. When we create an environment where employees perform their best, our delivery for clients will be the best it can be.

Learn more about our mission, vision, and values

Global Community Partners

We are proud of our signature Global Community Partners program, through which employees nominate organizations to receive catalytic financial support and significant volunteerism opportunities every two years.

More about our community partners

Our Latest News

  • Climb Bio, Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of Climb Bio, Inc. (CLYM $1.88), which is developing high-impact medicines for patients living with autoimmune diseases, with the CD19 antibody budoprutug as its lead program.

    Read more
  • William Blair Initiates Coverage of Two Oil and Gas Companies

    William Blair initiated research coverage of Expand Energy Corporation (EXE $102.68) and EQT Corporation (EQT $53.66), two leading natural gas producers with operations concentrated in the Appalachian Basin.

    Read more
  • William Blair Serves as Exclusive Financial Advisor to Vantaca in its Minority Growth Investment From Cove Hill Partners

    William Blair acted as the exclusive financial advisor to Vantaca in connection with its $300-plus million minority growth investment from Cove Hill Partners at a $1.25 billion valuation.

    Read more

Join Our Team

Finding, attracting, and developing talented people is the foundation of our success. Learn about the promising career opportunities currently available at William Blair.

Search our job openings
Women sitting outside with a laptop

Delivered to Your Inbox

Stay up-to-date with the latest William Blair news and insights

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures